Evaluation of Comparative Surveillance Strategies of Circulating Tumor DNA, Imaging, and Carcinoembryonic Antigen Levels in Patients With Resected Colorectal Cancer

IMPORTANCE: A circulating tumor DNA (ctDNA) assay (Signatera; Natera) has been marketed for use in the surveillance of resected colorectal cancer despite limited data supporting such practice. OBJECTIVE: To compare a ctDNA assay with standard radiographic imaging and measurement of carcinoembryonic...

Descripción completa

Detalles Bibliográficos
Autores principales: Fakih, Marwan, Sandhu, Jaideep, Wang, Chongkai, Kim, Jae, Chen, Yi-Jen, Lai, Lily, Melstrom, Kurt, Kaiser, Andreas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Medical Association 2022
Materias:
Original Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8905389/
https://www.ncbi.nlm.nih.gov/pubmed/35258578
http://dx.doi.org/10.1001/jamanetworkopen.2022.1093

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8905389/
https://www.ncbi.nlm.nih.gov/pubmed/35258578
http://dx.doi.org/10.1001/jamanetworkopen.2022.1093

Ejemplares similares